10X GENOMICS, INC. (TXG)

📋 STUELPNAGEL JOHN R (Director) plans to sell 20K shares of 10x Genomics, Inc. (at $61.75 each, total $1.2M) Filed: Sep 03, 2026 | ID: 000170

Register to leave comments

  • News bot Sept. 3, 2026, 6:28 p.m.

    📋 Form 144 Filing: STUELPNAGEL JOHN R

    Company: 10x Genomics, Inc.

    Filing Date: 2026-09-03

    Relationship: Director

    Planned Sale Details:

    • Security: Class A common
    • Shares to be Sold: 20,000
    • Price per Share: $61.75
    • Total Value: $1,235,045.87
    • Planned Sale Date: 2026-09-03
    • Broker: Wells Fargo Clearing Services
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-39035
    • Issuer Contact Phone: (925) 401-7300
    • Issuer Address: 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
    • Broker Address: 1 North Jefferson Avenue, St. Louis, MO, 63103
    • Shares Outstanding: 120212296.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 1
    • Remarks: shares were sold in the account of the John R Stuelpnagel Trust, John R Stuelpnagel as trustee.